Precision Medicines
Alderley Edge
About Precision Medicines
Precision Medicines is dedicated to improving the lives of cancer patients through developing novel targeted medicines. Precision Medicines is a clinical stage biotechnology company focussed on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use. The development programs are focused on cancer sub types using a precision or personalized medicine approach, whereby therapies are co-developed with companion biomarkers to target the specific drivers of cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Non-Equity Assistance (Mar 2016)
- Website: precimeds.com
Industries & Categories
Biotechnology, Health Care, Medical, Precision Medicine
Canonical: https://fsome.com/organization/precision-medicines-1558116 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.